Novo Nordisk stock crashed Friday after the Danish giant reported its experimental obesity drug CagriSegma missed goals. Eli ...

A new report from Vermont's health care regulators shows that the state could have saved $400 million in hospital costs over ...

World models, also known as world simulators, are being touted by some as the next big thing in AI. World models take inspiration from the mental models of the world that humans develop naturally.

(Bloomberg) -- Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, ...

OpenAI launched Strawberry — another name for its its 01 model — on Sept. 12, including the full function o1-preview and the more affordable o1-mini to demonstrate how AI can be greatly ...

More than $50 million announced to rebuild Fiona-damaged Evangeline school The new Évangéline Education Centre will be built on the same site as the existing school. It will hold 225 school-aged ...

Eli Lilly, the company that makes the blockbuster weight loss treatment Zepbound, will start studying its obesity products as treatments for alcohol and drug addiction, making it the first major ...

Will Tesla's new, affordable electric vehicle be called Tesla Model Q? Don't hold your breath for the name, but a cheaper Tesla is, apparently, coming. A Deutsche Bank report mentions the new ...

ðÿ €üí—Õ×ï+{v7© ( dÓs]}Ý?)TLè¨0B ÓVþo­2îmŒÈ‹± úœÈûPõR==³p8{» HUõ«g{fú ñùÈ OàÈù vq 26.^f ª6[úÞfž B ÛM}ÿ!¤1‹ Ù ôêP>PuÁé)â&ø¿ÑÝ ¦[n ü¸Ø ...

Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market. It'll take a while for the economic implications of the data to play out.

(Bloomberg) — Eli Lilly & Co. approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled in part by the blockbuster weight-loss drug Zepbound. The company ...

Google’s DeepMind team unveiled an AI model for weather prediction this week called GenCast. In a paper published in Nature, DeepMind researchers said they found that GenCast outperforms the ...